METRONIDAZOLE TABLETS

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC, with a total value of $58.68, for the delivery of 4.000 PG of Metronidazole Tablets identified by NSN 6505011424914 and NDC 00904-7156-61. The award was issued on July 14, 2026, with a required delivery date of July 29, 2026, and FOB destination terms placing full shipping responsibility and cost on the contractor. The delivery is to be made to Fort Stewart, Georgia, with strict traceability requirements mandating the inclusion of a Transaction Control Number W33RBS61940146 and the full shipping address in the MARKFOR field, alongside the referenced NSN and CAGE code 1LEZO for the manufacturer. Packaging must support end-to-end traceability, and parcel post is explicitly prohibited, though no specific military standards such as MIL-STD-129 are cited. Inspection and acceptance occur at the destination, and no detailed technical, quality, or preservation specifications are provided beyond alignment with DoD authorized units and pharmaceutical supply protocols. The contract contains no options, modifications, clause references, attachments, or special requirements beyond the single-line delivery, and no contracting officer, COR, COTR, payment office, or invoicing method details are listed. The procurement is treated as a straightforward commercial supply transaction, with no socioeconomic certifications, representations, or evaluation criteria disclosed, consistent with a low-dollar-value, LPTA-type award under the broader DLA framework.